Should You Follow Directors Buying Shares Of Shire PLC, Greene King plc And Paypoint plc?

Is it time to pile into Shire PLC (LON:SHP), Greene King plc (LON:GKP) and Paypoint plc (LON:PAY) as directors buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Directors have been buying big-time at Shire (LSE: SHP), Greene King (LSE: GNK) and Paypoint (LSE: PAY). Should you follow their lead, and load up on shares of these three companies?

Shire

The top brass at FTSE 100 pharma firm Shire have been buying with a vengeance since the company released its annual results last Thursday. As the table below shows, we’ve seen purchases by the chief executive and chairman, a below-board-level manager, or ‘person discharging managerial responsibility’ (PDMR), and four non-executive directors.

Name

No. of shares/ADSs*

Price per share

Total investment

Flemming Ornskov (chief executive)

1,300*

1,300*

$160.30

$154.12

$208,390

$200,356

Susan Kilsby (chairman)

1,600*

$158.4134

$253,461

Bill Mordan (PDMR)

1,000*

$154.12

$154,120

Steven Gillis (non-exec)

300*

$154.7699

$46,431

Bill Burns (non-exec)

1,250

£35.6310

£44,539

Olivier Bohuon (non-exec)

1,000

£35.5212

£35,521

Anne Minto (non-exec)

280

£35.60

£9,968

* American Depository Shares (ADSs) are equal to three ordinary shares.

Shire’s agreement to buy US rare disease specialist Baxalta for $32bn hasn’t met with the approval of all shareholders, and the Footsie firm’s shares have fallen by more than a third since the deal was proposed last August.

However, chief executive Flemming Ornskov is adamant that combining with Baxalta to create the global leader in the highly profitable niche of treating rare diseases is a compelling proposition for Shire. And he and other board members are certainly putting their money where their mouths are.

Most of their buys were at a price below £36 (or the ADS dollar equivalent). The shares are now up above £37, but still look attractively-valued at 15.5 times last year’s earnings, if growth from the Baxalta deal lives up to Mr Ornskov’s expectations.

Greene King

Philip Yea has a blue-chip CV that includes roles as finance director of Diageo, chief executive of 3i Group and senior independent director of Vodafone. He joined the board of FTSE 250 brewer and pubs operator Greene King on 2 February and will take over from retiring chairman Tim Bridge on 2 May.

Mr Yea was barely through the boardroom door when he made a maiden purchase of Greene King shares last Thursday, the day after the company released an upbeat trading statement. He splashed out £257,694 to buy 30,000 shares at 858.98p a pop.

The trading statement said management’s expectations for the year ending 30 April are unchanged, and I can understand why Mr Yea was so keen to open his wallet, with Greene King trading on an undemanding 13 times forecast earnings.

Paypoint

The UK’s leading payment network Paypoint released a trading update on 28 January in which it said that progress had been partially offset by a few minor hiccups. As the shares went into decline, directors began to buy, investing a combined total of over £230,000.

Chairman Nicholas Wiles was first out of the blocks, purchasing 10,000 shares at 797p a pop on 29 January. Non-exec Giles Kerr bought cheaper on 5 February: 7,500 shares at 779p. Fellow non-execs Neil Carson and Gill Barr did even better by waiting until last week, snapping up 10,000 shares at 738p, in Mr Carson’s case, and 2,595 at 728p, in Miss Barr’s case.

Paypoint’s shares have recovered somewhat to 741.5p at Tuesday’s close, and the valuation of 13.5 times forecast earnings for the year ending 31 March looks attractive, as strong growth is pencilled-in for fiscal 2017.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be considered so you should consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK owns shares of PayPoint. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Using the price-to-earnings metric to find the cheapest UK shares to buy now!

There’s certainly no shortage of value UK shares right now. I'm finding the cheapest stocks for my portfolio using the…

Read more »

Man changing battery on electric bicycle
Investing Articles

Stock market recovery: my top 2 FTSE 100 shares to buy this month!

The UK index might be trading above 7,500, but many FTSE 100 shares still haven't recovered. In fact, plenty trade…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

4 of my best shares to buy for an autumn stock market bounce

Jon Smith explains which are his best shares to buy depending on different scenarios behind a potential market rally.

Read more »

Risk reward ratio / risk management concept
Investing Articles

Is the GSK share price good value after the 13% fall last week?

Jon Smith considers the reason behind the sharp fall in the GSK share price last week, and wonders if now…

Read more »

Young black woman in a wheelchair working online from home
Investing Articles

At under 5p, are Woodbois shares a no-brainer buy now?

I didn't buy Woodbois shares when they were up over 8p. Now they've fallen back, I'm wondering if I'm seeing…

Read more »

Business development to success and FTSE 100 250 350 growth concept.
Investing Articles

Are we about to see a raging bull market for shares?

Investor sentiment looks like it's changing and we could be in the early stages of a bull market for shares…

Read more »

Black father holding daughter in a field of cows
Investing Articles

I’m investing just £5 a day in income stock to aim for £8,000 a year in passive revenue!

Income stocks form the core part of my portfolio, offering me passive income with minimal effort. But I'm reinvesting my…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

3 dividend hero stocks for a monthly passive income

This Fool discusses the investment trusts capable of paying him a lifetime of growing passive income to supplement his portfolio…

Read more »